Fig. 3
Illustration of utility gains or disutilities associated with different aspects of haemophilia treatment (S1). SC: Subcutaneous, IV: Intravenous
Fig. 3 | Health and Quality of Life Outcomes
Illustration of utility gains or disutilities associated with different aspects of haemophilia treatment (S1). SC: Subcutaneous, IV: Intravenous